Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
J Matern Fetal Neonatal Med. 2022 Dec;35(23):4461-4468. doi: 10.1080/14767058.2020.1852208. Epub 2020 Dec 1.
Among deliveries <34 weeks, there is inconclusive evidence regarding the preferred route of delivery when there is a need to expedite delivery during the second stage of labor. As it is unreasonable that future randomized controlled trials will be conducted to settle this query, every clinical data concerning this topic, may be helpful. We aim to compare neonatal outcomes among women undergoing emergent cesarean delivery (ECD) versus vacuum-assisted delivery (VAD) during the second stage of labor among singleton gestations <34 weeks.
A retrospective cohort study including all women who underwent either ECD or VAD at the second stage of labor between 30° and 33weeks, during 2011-2019. The primary outcome was the rate of adverse neonatal outcomes, defined as intrapartum death, mechanical ventilation, asphyxia, respiratory distress syndrome, subgaleal hemorrhage, intraventricular hemorrhage, necrotizing enterocolitis, and phototherapy.
Of the 153,672 live singleton deliveries during the study period, 2871 (1.9%) delivered before 34°. Of those 1674 (58.3%) delivered vaginally unassisted and 1137 (39.6%) delivered by a CD during the first stage of labor. A total of 60 deliveries were analyzed, with a median gestational age of 32 weeks, interquartile range (IQR) 31-33. Median birth weight at delivery was 1845 g, IQR 1574-2095. Overall 25 (42%) of women were delivered by VAD and 35 by CD (58%). Indications for expeditious delivery did not differ between the study groups. Neonates delivered by VAD had a higher median birth weight (1940 vs. 1620 g, = .02). Second stage of labor was longer in the ECD group as compared to the VAD group (median 200 vs. 52 min, = .01). The rate of Apgar score at 1 min <7 was higher among the CD group (10 (40%) vs. 5 (14%), OR [95% CI]: 4.0 (1.1-13.8), = .03). Longer length of stay was evident in the CD group as compared to the VAD group (median 30 vs. 21 days, = .001). The rate of composite neonatal adverse outcome was comparable between the study groups. Adverse outcomes were associated with lower body mass index (median 27.7 vs. 34.9, = .04), higher rate of premature preterm rupture of membranes (40 (91%) vs. 5 (31%), OR [95% CI]: 22.0 (5.0-91.1), < .001) and labor dystocia as the indication for expedited delivery (38 (86%) vs. 7 (44%), OR [95% CI]: 8.1 (2.1-30.1), = .001).
Cesarean delivery during the second stage of labor of gestations <34 weeks was associated with a higher rate of lower Apgar scores and longer length of stay.
Delivery by second stage CD of premature neonates <34 weeks is associated with a higher rate of lower Apgar score.
在<34 周的分娩中,当第二产程需要加速分娩时,对于首选的分娩方式尚无定论。由于没有理由进行未来的随机对照试验来解决这个问题,因此与这个话题相关的每一项临床数据都可能会有所帮助。我们旨在比较 30°至 33 周之间第二产程中紧急剖宫产(ECD)与真空辅助分娩(VAD)的新生儿结局。
一项回顾性队列研究,纳入了 2011 年至 2019 年期间在第二产程中进行 ECD 或 VAD 的所有<34 周单胎妊娠妇女。主要结局是产时不良新生儿结局的发生率,定义为产时死亡、机械通气、窒息、呼吸窘迫综合征、帽状腱膜下血肿、脑室出血、坏死性小肠结肠炎和光疗。
在研究期间,共有 153672 例活产单胎分娩,2871 例(1.9%)分娩时间<34 周。其中 1674 例(58.3%)未经阴道辅助分娩,1137 例(39.6%)在第一产程中进行了剖宫产。共分析了 60 例分娩,中位孕龄为 32 周,四分位间距(IQR)为 31-33。中位出生体重为 1845 克,IQR 为 1574-2095。总体而言,25 例(42%)产妇行 VAD 分娩,35 例行 CD 分娩(58%)。紧急分娩的指征在两组之间没有差异。与 VAD 组相比,ECD 组第二产程更长(中位数 200 对 52 分钟, = .01)。与 VAD 组相比,CD 组 1 分钟时 Apgar 评分<7 的新生儿比例更高(10(40%)对 5(14%),OR [95% CI]:4.0(1.1-13.8), = .03)。与 VAD 组相比,CD 组的住院时间更长(中位数 30 对 21 天, = .001)。两组间复合新生儿不良结局的发生率相似。不良结局与较低的体重指数(中位数 27.7 对 34.9, = .04)、较高的早产胎膜早破发生率(40(91%)对 5(31%),OR [95% CI]:22.0(5.0-91.1), < .001)和作为加速分娩指征的产程难产(38(86%)对 7(44%),OR [95% CI]:8.1(2.1-30.1), = .001)有关。
<34 周妊娠的第二产程行剖宫产与较低的 Apgar 评分和较长的住院时间有关。
对于<34 周的早产儿,在第二产程行剖宫产会导致较低的 Apgar 评分和较长的住院时间。